Avidity Biosciences, Inc.
RNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$174,442 | -$157,315 | -$115,773 | -$102,257 |
| Dep. & Amort. | $1,056 | -$7,818 | $785 | $738 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $19,024 | $17,659 | $17,736 | $14,153 |
| Change in WC | -$516 | -$58,170 | -$23,244 | -$6,163 |
| Other Non-Cash | -$1,295 | $5,978 | -$4,333 | -$6,342 |
| Operating Cash Flow | -$156,173 | -$199,666 | -$124,829 | -$99,871 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$712 | -$3,343 | -$3,753 | -$3,916 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$853,603 | -$74,001 | -$169,270 | -$297,001 |
| Inv. Sales/Matur. | $269,564 | $262,829 | $330,211 | $236,745 |
| Other Inv. Act. | -$3,175 | $0 | $0 | $0 |
| Investing Cash Flow | -$587,926 | $185,485 | $157,188 | -$64,172 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $837,420 | $3,773 | $1,937 | -$141,895 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $12,946 | $0 | $0 | $155,619 |
| Financing Cash Flow | $850,366 | $3,773 | $1,937 | $13,724 |
| Forex Effect | -$16 | $115 | $39 | $0 |
| Net Chg. in Cash | $106,251 | -$10,293 | $34,335 | -$150,319 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $246,705 | $256,998 | $219,868 | $372,982 |
| End Cash | $352,956 | $246,705 | $254,203 | $222,663 |
| Free Cash Flow | -$160,060 | -$203,009 | -$128,582 | -$103,787 |